Mary E. Ropka

3.5k total citations
62 papers, 2.6k citations indexed

About

Mary E. Ropka is a scholar working on General Health Professions, Public Health, Environmental and Occupational Health and Oncology. According to data from OpenAlex, Mary E. Ropka has authored 62 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in General Health Professions, 17 papers in Public Health, Environmental and Occupational Health and 13 papers in Oncology. Recurrent topics in Mary E. Ropka's work include BRCA gene mutations in cancer (13 papers), Palliative Care and End-of-Life Issues (12 papers) and Patient-Provider Communication in Healthcare (12 papers). Mary E. Ropka is often cited by papers focused on BRCA gene mutations in cancer (13 papers), Palliative Care and End-of-Life Issues (12 papers) and Patient-Provider Communication in Healthcare (12 papers). Mary E. Ropka collaborates with scholars based in United States, United Kingdom and Canada. Mary E. Ropka's co-authors include John T. Philbrick, Victoria Mock, Mary Pickett, Ruth McCorkle, Kerry J. Stewart, Laura Jean Podewils, Verna A. Rhodes, Roxanne W. McDaniel, Patricia M. Grimm and Esther Muscari Lin and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and Acta Neuropathologica.

In The Last Decade

Mary E. Ropka

60 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary E. Ropka United States 23 1.1k 686 657 568 451 62 2.6k
Ingrid Oakley‐Girvan United States 27 927 0.8× 632 0.9× 289 0.4× 553 1.0× 471 1.0× 68 2.7k
Kristi D. Graves United States 30 1.1k 1.0× 1.2k 1.7× 727 1.1× 506 0.9× 704 1.6× 122 2.9k
June Carroll Canada 35 550 0.5× 1.2k 1.7× 1.0k 1.5× 672 1.2× 1.0k 2.3× 146 3.6k
Dejana Braithwaite United States 27 1.0k 0.9× 462 0.7× 248 0.4× 305 0.5× 397 0.9× 59 2.5k
Kate Brain United Kingdom 31 1.3k 1.1× 731 1.1× 299 0.5× 851 1.5× 639 1.4× 104 3.1k
T. Gregory Hislop Canada 32 1.2k 1.0× 256 0.4× 273 0.4× 670 1.2× 537 1.2× 56 3.3k
Iraj Harirchi Iran 27 1.9k 1.7× 452 0.7× 250 0.4× 409 0.7× 254 0.6× 73 3.0k
Vanessa B. Sheppard United States 34 1.4k 1.2× 587 0.9× 423 0.6× 1.0k 1.8× 854 1.9× 148 3.5k
Maria C. Katapodi United States 25 1.4k 1.3× 875 1.3× 505 0.8× 558 1.0× 886 2.0× 71 3.3k
Donna Buono United States 23 906 0.8× 402 0.6× 303 0.5× 318 0.6× 318 0.7× 45 3.2k

Countries citing papers authored by Mary E. Ropka

Since Specialization
Citations

This map shows the geographic impact of Mary E. Ropka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Ropka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Ropka more than expected).

Fields of papers citing papers by Mary E. Ropka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Ropka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Ropka. The network helps show where Mary E. Ropka may publish in the future.

Co-authorship network of co-authors of Mary E. Ropka

This figure shows the co-authorship network connecting the top 25 collaborators of Mary E. Ropka. A scholar is included among the top collaborators of Mary E. Ropka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary E. Ropka. Mary E. Ropka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fleisher, Linda, Suzanne M. Miller, Michael A. Diefenbach, et al.. (2015). Development and utilization of complementary communication channels for treatment decision making and survivorship issues among cancer patients: The CIS Research Consortium Experience. Internet Interventions. 2(4). 392–398. 7 indexed citations
2.
Wen, Kuang‐Yi, Suzanne M. Miller, Annette L. Stanton, et al.. (2012). The development and preliminary testing of a multimedia patient–provider survivorship communication module for breast cancer survivors. Patient Education and Counseling. 88(2). 344–349. 16 indexed citations
3.
Jones, Randy, Richard H. Steeves, Mary E. Ropka, & Patricia J. Hollen. (2012). Capturing Treatment Decision Making Among Patients With Solid Tumors and Their Caregivers. Oncology nursing forum. 40(1). E24–E31. 20 indexed citations
4.
Sprangers, Mirjam A. G., Meike Bartels, Ruut Veenhoven, et al.. (2010). Which patient will feel down, which will be happy? The need to study the genetic disposition of emotional states. Quality of Life Research. 19(10). 1429–1437. 25 indexed citations
5.
Cohn, Wendy, Mary E. Ropka, Mable B. Kinzie, et al.. (2010). Health Heritage<sup>©</sup>, a Web-Based Tool for the Collection and Assessment of Family Health History: Initial User Experience and Analytic Validity. Public Health Genomics. 13(7-8). 477–491. 73 indexed citations
6.
Ropka, Mary E. & Geraldine Padilla. (2007). Assessment of Neutropenia-Related Quality of Life in a Clinical Setting. Oncology nursing forum. 34(2). 403–409. 8 indexed citations
7.
Ropka, Mary E., Geraldine Padilla, & Theresa Gillespie. (2005). Risk Modeling: Applying Evidence-Based Risk Assessment in Oncology Nursing Practice. Oncology nursing forum. 32(1). 49–56. 6 indexed citations
8.
Padilla, Geraldine & Mary E. Ropka. (2005). Quality of Life and Chemotherapy-induced Neutropenia. Cancer Nursing. 28(3). 167???171–167???171. 35 indexed citations
9.
Santen, Richard J., JoAnn V. Pinkerton, Mark Conaway, et al.. (2002). Treatment of urogenital atrophy with low-dose estradiol: preliminary results. Menopause The Journal of The North American Menopause Society. 9(3). 179–187. 85 indexed citations
10.
Pickett, Mary, et al.. (2002). Adherence to Moderate‐Intensity Exercise During Breast Cancer Therapy. Cancer Practice. 10(6). 284–292. 101 indexed citations
11.
Mock, Victoria, Mary Pickett, Mary E. Ropka, et al.. (2001). Fatigue and Quality of Life Outcomes of Exercise During Cancer Treatment. Cancer Practice. 9(3). 119–127. 381 indexed citations
12.
McGuire, Deborah B. & Mary E. Ropka. (2000). Research and oncology nursing practice. Seminars in Oncology Nursing. 16(1). 35–46. 6 indexed citations
13.
Cohn, David L., Evelyn J. Fisher, James S. Hodges, et al.. (1999). A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients. 67. 1 indexed citations
14.
Cohn, David L., Evelyn J. Fisher, James S. Hodges, et al.. (1999). A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: Excess mortality associated with high-dose clarithromycin. 67. 520–521. 1 indexed citations
15.
16.
Ropka, Mary E. & Ann K. Williams. (1998). HIV nursing and symptom management. 14 indexed citations
17.
Hench, Karen, Robin Anderson, Christine Grady, & Mary E. Ropka. (1995). Investigating chronic symptoms in HIV: An opportunity for collaborative nursing research. Journal of the Association of Nurses in AIDS Care. 6(3). 13–17. 8 indexed citations
18.
Ropka, Mary E., et al.. (1991). Effective Head and Neck Tumor Markers: The Continuing Quest. Archives of Otolaryngology - Head and Neck Surgery. 117(9). 1011–1014. 20 indexed citations
19.
Philbrick, John T., et al.. (1990). Restoring Balance to Internal Medicine Training: The Case for the Teaching Office Practice. The American Journal of the Medical Sciences. 299(1). 43–49. 7 indexed citations
20.
Ropka, Mary E., et al.. (1984). Clinical nurse specialist--alive and well?. PubMed. 84(5). 661–2,664. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026